| Class / Patent application number | Description | Number of patent applications / Date published |
|---|
| 514762000 | Hydrocarbon DOAI | 42 |
| 20080269352 | Method for Producing Hydrocarbons - A process is provided for the production of linear saturated alkanes from one or more primary alcohols, wherein the carbon chain of the one or more primary alcohols has one carbon atom more than the alkane, including conducting reductive dehydroxymethylation of one or more primary fatty alcohols containing 8 to 24 carbon atoms, at a temperature ranging from 100 to 300° C. and pressures from 1 to 250 bar in the presence of hydrogen and a catalyst, and removing water formed during the reaction. | 10-30-2008 |
| 20080293826 | COSMETIC COMPOSITIONS WITH ETHOXYLATED URETHANE - A cosmetic composition is provided which includes petrolatum, water, and ethoxylated urethane. This composition retains stable viscosity without being sticky or tacky and can easily be rubbed into skin. | 11-27-2008 |
| 20090036546 | Medicinal Oil Compositions, Preparations, and Applications Thereof - A medicinal white oil composition is prepared from an isomerized base oil. The isomerized base oil is filtered through a filter bed containing an acid activated clay having a surface area of at least 100 m | 02-05-2009 |
| 20090111896 | Use of Hydrocarbon Fluids In Seed Treatment - Treatment of seeds with hydrocarbon fluids improve germination under adverse conditions. | 04-30-2009 |
| 20090156690 | Deodorizing Exfoliator - Disclosed is a method of treating body odor by scrubbing onto the skin a mixture of salt, one or more humectants, and one or more essential oils, with the salt being a gritty solid component in suspension within the other components so that the mixture is a viscously heterogeneous composition, which feels gritty to the touch and which exfoliates and moisturizes the skin when the mixture is scrubbed onto the skin, where the scrubbing allows the humectant(s) to penetrate into the skin. After scrubbing, the mixture is rinsed off of the skin (particularly the salt) with water, leaving a portion of mixture (minus the salt) remaining on the skin to terminate any residual fungi or bacteria, and to continue inhibiting the growth of new fungi and bacteria, while giving the skin a fragrance. | 06-18-2009 |
| 20090298951 | Nontoxic Biocidal Composition And Method Thereof - This invention discloses biocidal compositions and methods and more particularly, a novel nontoxic biocide and biostat composition and method for elimination and inhibition of gram negative bacteria (microorganism), viral, and/or fungal growth, especially molds. In one formulation, the novel biocidal composition is formed from equal amounts of potassium sorbate, lecithin, cellulose, and wax in a suspension with distilled mineralized water, preferably distilled mineralized water in combination with about 15% catalyst activated fluorine and chlorine free water. Using cellulose as a carrier for a wax to be ingested by a microorganism, fungal spore or virus is effective as a biocide because the ingested wax encapsulates the microorganism, fungal spore or virus, thereby effectively suffocating it. | 12-03-2009 |
| 20090318567 | LYCOPENE FOR THE TREATMENT OF METABOLIC DYSFUNCTION - This invention relates to the treatment of metabolic dysfunction and disorders associated with metabolic dysfunction using lycopene compounds. Methods of treatment and uses of lycopene compounds in such methods are provided. | 12-24-2009 |
| 20100016447 | SPRAY OIL AND METHOD OF USE THEREOF FOR CONTROLLING TURFGRASS PESTS - A paraffinic spray oil and a method of using the spray oil for controlling turfgrass pests is disclosed. The spray oil comprises paraffinic oil and a quick break emulsifier, which is formulated as an oil-in-water (O/W) emulsion for use. The paraffinic oil and emulsifier are present in a weight ratio ranging from about 95:5 to about 99.95:0.05, and preferably from about 98.5:1.5 to about 99.9:0.1. When applied to turfgrass, the O/W emulsion quickly releases the oil phase upon application to the turfgrass to contact pests thereon. When provided at sufficient paraffinic oil dosages, generally at least about 0.5 gal oil/acre and preferably in the range of about 0.5 gal/acre to about 60 gal/acre, the spray oil is effective in controlling a variety of turfgrass pests, particularly insect and fungal pests, with little or no phytotoxic effects. Further, use of the spray oil as indicated for controlling turfgrass pests also enhances the growth of turfgrass. | 01-21-2010 |
| 20100190867 | STABLE AND BIOAVAILABLE COMPOSITIONS OF ISOMERS OF LYCOPENE FOR SKIN AND HAIR - The present invention relates to a method of manufacturing a stable composition enriched in cis-lycopene (z-isomers) by prolonged heating in solvents of tomatoes, parts of tomatoes, derivative thereof or tomato extracts in solvents. | 07-29-2010 |
| 20120316249 | LYCOPENE FOR THE TREATMENT FOR METABOLIC DYSFUNCTION - This invention relates to the treatment of metabolic dysfunction and disorders associated with metabolic dysfunction using lycopene compounds. Methods of treatment and uses of lycopene compounds in such methods are provided. | 12-13-2012 |
| 20130172426 | FAT-REDUCING AGENT - A fat-reducing agent includes a carotenoid-containing composition as an active ingredient, the carotenoid-containing composition including: a carotenoid component including at least one crystalline carotenoid, wherein at least 90% by mass of the crystalline carotenoid is in the non-crystalline state; and a (poly)glycerin fatty acid ester containing from 1 to 6 glycerin units and from 1 to 6 fatty acid units, and having at least one hydroxyl group in the glycerin units. | 07-04-2013 |
| 20130261193 | Pheromone Compositions and Methods of Use - Pheromone compositions based on a combination of squalene, linoleic acid and 1-docosanol are described. The compositions are useful for behavior modification in mammals that exhibit undesirable or harmful stress-related behaviors. | 10-03-2013 |
| 20130324620 | Spray Oil and Method of Use Thereof for Controlling Turfgrass Pests - A paraffinic spray oil and a method of using the spray oil for controlling turfgrass pests is disclosed. The spray oil comprises paraffinic oil and a quick break emulsifier, which is formulated as an oil-in-water (O/W) emulsion for use. The paraffinic oil and emulsifier are present in a weight ratio ranging from about 95:5 to about 99.95:0.05, and preferably from about 98.5:1.5 to about 99.9:0.1. When applied to turfgrass, the O/W emulsion quickly releases the oil phase upon application to the turfgrass to contact pests thereon. When provided at sufficient paraffinic oil dosages, generally at least about 0.5 gal oil/acre and preferably in the range of about 0.5 gal/acre to about 60 gal/acre, the spray oil is effective in controlling a variety of turfgrass pests, particularly insect and fungal pests, with little or no phytotoxic effects. Further, use of the spray oil as indicated for controlling turfgrass pests also enhances the growth of turfgrass. | 12-05-2013 |
| 20140057995 | AQUEOUS-LIPIDIC CAROTENOID-CONTAINING COMPOSITIONS - The invention provides a primary carotenoid-containing composition comprising an aqua-containing component, a lipid-containing component and a carotenoid-containing fiber material from plant origin with lowered content of aqua-soluble substances. The invention also provides oral compositions that comprise the primary composition in a foodstuff, in a food supplement or in a pharmaceutical preparation. | 02-27-2014 |
| 20140088201 | METHOD FOR THE PREPARATION AND EXTRACTION OF SQUALENE FROM MICROALGAE - The invention relates to a method for the production of squalene from microalgae belonging to the family of Thraustochytriales sp., preferably at concentrations of between 2 and 12 g per 100 g of dry biomass. The method is characterised in that it comprises steps consisting in: culturing microalgae belonging to the family of Thraustochytriales sp. at a temperature of between 25 and 35° C., preferably between 28 and 32° C., and more preferably of the order of 30° C.; and adding between 1 and 1000 μg of vitamin B12 per litre of culture medium to said culture medium. | 03-27-2014 |
| 20140288187 | COCOA-BASED FOOD PRODUCTS - The invention is concerned with food products comprising one or more cocoa bean products and a carotenoid compound, particularly with food products which are, or comprise, chocolate. The products of the invention may be used in reducing elevated total cholesterol, triglycerides and inflammatory damage, as well as improving tissue microcirculation and tissue oxygenation. | 09-25-2014 |
| 20140336272 | Petrolatum Composition - A petrolatum composition comprises from 10 to 60 wt % of a wax having an average number of carbon atoms per molecule of between 25 and 70, and having between 5 and 50 wt % branched paraffins in which the branches are selected from methyl and ethyl branches; from 10 to 60 wt % of a linear paraffin having an average number of carbon atoms per molecule of between 10 and 20; and optionally, a low melt wax. The petrolatum composition has a drop melt point of from 35° C. to 80° C. | 11-13-2014 |
| 20160198723 | Spray Oil And Method Of Use Thereof For Controlling Turfgrass Pests | 07-14-2016 |
| 20160251644 | NOVEL POLYPEPTIDES AND USES THEREOF | 09-01-2016 |
| 514763000 | Carbocyclic | 23 |
| 20080255246 | Use of bipolar trans carotenoids as a pretreatment and in the treatment of peripheral vascular disease - The subject application relates to methods of treatment of peripheral vascular disease (PVD) as well as ischemic osteonecrosis, peritoneal ischemia, chronic ocular disease, macular degeneration, or diabetic retinopathy, comprising administering a therapeutically effective amount of a trans carotenoid. The invention also relates to the use of such carotenoids as pretreatments for mammals at risk of an ischemic event. | 10-16-2008 |
| 20080280996 | Use of Carophyllenes in the Manufacture of Medicaments and Treatment of Bodily Conditions of Inflammation and Inflammatory Pain - The invention concerns the use of caryophyllenes related to medicaments and to the treatment of bodily conditions of inflammation and inflammatory pain. | 11-13-2008 |
| 20090176890 | EDIBLE PLANT EXTRACT BASED INSECTICIDAL COMPOSITION - A food-grade insecticidal composition allowed for use in organic production which is effective in controlling insects, such as ants, aphids, mealy bugs, white flies, spider mites, leaf hoppers, cabbage loopers, leaf eating beetles and caterpillars, cockroaches, flies, wasps, mosquitoes, wood boring and eating insects, and body and head lice but which is non-toxic to humans, household animals, and farm animals includes an effective insect-controlling amount of D-limonene, a non-toxic emulsifying agent, and a non-toxic hydrophilic solvent. | 07-09-2009 |
| 20090203801 | METHODS OF INHIBITING ETHYLENE RESPONSES IN PLANTS USING DICYCLOPROPENE COMPOUNDS - Methods of applying dicyclopropene compounds and compositions thereof to block ethylene receptors in plants are disclosed. Methods include applying to the plant an effective ethylene response-inhibiting amount of a dicyclopropene compound or composition thereof. Dicyclopropene compounds, enantiomers, stereoisomers or salts thereof are also provided. | 08-13-2009 |
| 20090306222 | FOOD SUPPLEMENTS AND USES THEREOF - The invention features compositions for administration of an oxidatively transformed carotenoid, fractionated oxidatively transformed carotenoid and components of oxidatively transformed carotenoid. The compositions are useful for supplementing the diet of an animal. | 12-10-2009 |
| 20110082218 | TREATMENT AND MODULATION OF GENE EXPRESSION AND SKIN AGING - Methods and compositions for treating modulating and/or ameliorating non-light-induced, particularly non-UV-induced, skin aging in a human, for reducing the basal MMP-10 expression in unirradiated cells of an organism and/or reducing the basal MMP-1 RNA transcription and protein translation in unirradiated cells of an organism, and/or for_modulating the effects of UVA-induced RNA transcription and polypeptide translation of a matrix metalloprotease, which include administering an effective amount of β-carotene, a precursor of β-carotene, a salt of β-carotene, or a combination of two or more thereof to an organism, particularly a mammal, more particularly a human, in need to thereof. | 04-07-2011 |
| 20110207831 | READY-TO-USE, STABLE EMULSION - The present invention relates to a stable emulsion, ready for use, of fat-soluble vitamins or carotenoids, a process for the preparation thereof, and the use thereof as addition to animal feeds, human foods and dietary supplements, and cosmetic and pharmaceutical compositions. | 08-25-2011 |
| 20120071563 | STABILIZER - The present invention relates to a stabilizer comprising starch that comprises at least one ester group corresponding to the formula (I) | 03-22-2012 |
| 20120245232 | EMULSIFIABLE CONCENTRATE FOR A PHYTOSANITARY COMPOSITION, PHYTOSANITARY COMPOSITION AND PHYTOSANITARY FILM - An emulsifiable concentrate for emulsified phytosanitary composition, including more than 90% by weight of at least one mixture of hydrocarbons having a distillation cut greater than 250° C., less than 20% by weight of n-paraffins and less than 1% aromatics, and from 1 to 4% by weight of a mixture of at least two surfactants TA1 and TA2, such that TA2 is more hydrophobic than TA1, the HLB of the mixture of which varies from 6 to 10. | 09-27-2012 |
| 20120270954 | METHODS FOR MAINTAINING EYE HEALTH AND AMELIORATING OPTHALMIC MALADIES IN CANINES - The invention provides novel methods for maintaining eye health and ameliorating ophthalmic maladies in canines by administering to the canines an ophthalmic malady ameliorating amount of one or more carotenes. Generally, the carotenes are administered to the canines in amounts of from about 0.1 to about 5000 mg or in amounts of from about 0.1 to about 500 mg per day to ameliorate maladies such as impaired vision, cataracts, cloudy eye, retinal degeneration, eye injury caused by radiation, reducing or preventing a decline of social interaction, promoting overall health and wellness, improving the quality of life, and extending the prime for canines. | 10-25-2012 |
| 20120322892 | ORAL MICROEMULSION OF ELEMENE - An oral microemulsion of elemene is disclosed. The microemulsion is made of elemene, surfactant, cosurfactant and water or buffer solutions with pH 5˜8. Said surfactant is selected form tweens, polyoxyethylene castor oils, polyethylene glycol stearates and mixture thereof. Said cosurfactant is selected from ethanol, 1,3-propanediol, glycerol and mixture thereof. The concentration of elemene in the microemulsion is 1˜5 g/100 ml. The ratio of elemene, surfactant and cosurfactant is 1˜5(weight):1˜40(weight):1˜40(volume), wherein the unit of weight/volume is g/ml. | 12-20-2012 |
| 20130059922 | ANTI-TUMOR PLANT-MEDICAMENT SUSTAINED-RELEASE TABLET OF ELEMENE - Disclosed is an anti-tumor plant-medicament sustained-release tablet of elemene which comprises an elemene as an active component and is prepared by formulation of the elemene, a sustained-release agent, a bulking agent, a disintegrating agent, a binder and a lubricant, each component above-mentioned being in the following weight composition: the elemene 10%-15%, the sustained-release agent 3%-15%, the bulking agent 45%-70%, the disintegrating agent 3%-8%, the binder 1%-10%, and the lubricant 1%-8%. The sustained-release tablet of elemene provided in the invention has properties of expansion and adhesion, which in turn enables extending the retention time of the drug on upper and middle sections of the gastrointestinal tract. Therefore, the tablet may be taken b.i.d.×3, in order to attain reduction in fluctuation of the plasma concentration, maintain effective plasma concentration for a longer period, and reduce the irritation on the gastrointestinal tract. The skeleton-type sustained- and controlled-release formulation has advantages of low cost, easy control, and easy industrialized production. | 03-07-2013 |
| 20150018430 | HUMIDITY ACTIVATED FORMULATION FOR VOLATILE COMPOUNDS - This invention is related to controlled release formulations of volatile antimicrobial compounds against pathogens affecting meats, plants, or plant parts or dairy products. Provided are delivery systems in the form of coatings or films, where controlled release of their volatile components in vapor form is triggered by high relative humidity. The volatile component may include, for example volatile antimicrobial liquids including low molecular weight alcohols and/or aldehydes, 1-methylcyclopropene, and/or other volatile fungicides. | 01-15-2015 |
| 20150374598 | TREATMENT AND MODULATION OF GENE EXPRESSION AND SKIN AGING - Methods and compositions for treating modulating and/or ameliorating non-light-induced, particularly non-UV-induced, skin aging in a human, for reducing the basal MMP-10 expression in unirradiated cells of an organism and/or reducing the basal MMP-1 RNA transcription and protein translation in unirradiated cells of an organism, and/or for modulating the effects of UVA-induced RNA transcription and polypeptide translation of a matrix metalloprotease, which include administering an effective amount of β-carotene, a precursor of β-carotene, a salt of β-carotene, or a combination of two or more thereof to an organism, particularly a mammal, more particularly a human, in need thereof. | 12-31-2015 |
| 514764000 | Benzene ring containing | 6 |
| 20090036547 | INSECTICIDAL COMPOSITION - The present invention relates to the use of a composition comprising cymene as a larvicide against mosquito larvae of a genus other than | 02-05-2009 |
| 20120108675 | PROCESS AND APPARATUS FOR PRODUCING HYDROCARBONS BY HYDROGENATING A TERPENE FEED - The invention relates to a process and an apparatus for producing hydrocarbon components in the presence of a hydrodesulphurization catalyst. The components obtained by the process are suitable for use as fuel composition as such or as an additive in fuel compositions, and in cosmetics or pharmaceutical products. | 05-03-2012 |
| 20130053451 | Biocide Compositions (I) - Suggested are biocide compositions, comprising (a) at least one dialkylamide based on a hydroxycarboxylic acid, and (b) at least one biocide. The compositions exhibit an improved stability even if stored at temperatures between 5° and 40° C. over a longer period. | 02-28-2013 |
| 20130331462 | METHODS OF INHIBITING, PREVENTING, KILLING AND/OR REPELLING INSECTS USING SIMULATED BLENDS OF CHENOPODIUM - The present invention provides natural and/or simulated, synthetic, synergistic pesticidal compositions comprising terpenes, such as extracts from | 12-12-2013 |
| 20160165882 | METHODS OF INHIBITING, PREVENTING, KILLING AND/OR REPELLING INSECTS USING SIMULATED BLENDS OF CHENOPODIUM | 06-16-2016 |
| 514765000 | Polycyclo ring system | 1 |
| 20110251292 | MIXTURE AND METHOD FOR CONTROLLING THE INSECT ACROBASIS NUXVORELLA ON CARYA ILLINOIENSIS PLANTS - The invention consists of a mixture of organic chemicals avoiding the use of insecticides, and a method for pest control based on the mixture consisting in bringing about the premature eclosion of the hibernating larva and its possible death through inanition; experimentation has demonstrated it to be effective in bringing about the premature eclosion of the pecan nut casebearer or | 10-13-2011 |
| 514766000 | Polycyclo ring system | 3 |
| 20080300319 | METHODS FOR PREVENTING OR INHIBITING POST-SURGICAL ADHESIONS - In accordance with one aspect of the invention, a method is provided in which post-surgical adhesions at a surgical site in a patient are prevented or inhibited. The method comprises topically applying a liquid composition comprising a hydrophobic species, which has a melting point above normal body temperature, to tissue at the surgical site in an amount effective to prevent or inhibit the formation of adhesions during healing. Application of the liquid composition results in the formation of a solid adhesion barrier layer on the tissue. Moreover, the properties of the hydrophobic species are such that the adhesion barrier sublimes in vivo after the surgical site is closed. In another aspect, A medical device that comprises first and second lumens, wherein the medical device is configured to deliver a first fluid medium through the first lumen at a temperature above normal body temperature and to concurrently or sequentially deliver a second fluid medium through the second lumen at a temperature below normal body temperature. | 12-04-2008 |
| 20120035274 | Composition for Prevention or Treatment of Obesity, Dyslipidemia, Fatty Liver or Insulin Resistance Syndrome Comprising Camphene as Active Ingredients - Disclosed is a composition including camphene as an active ingredient for preventing or treating obesity, dyslipidemia, fatty liver or insulin resistance syndrome. The composition of the present disclosure including camphene as an active ingredient suppresses differentiation of adipocytes, reduces body fat, reduces visceral fat, reduces total cholesterol level, reduces serum triglyceride level and reduces liver tissue triglyceride level, and thus exhibits preventive or therapeutic activity for obesity, hyperlipidemia or fatty liver. Furthermore, the composition of the present disclosure exhibits the effect of improving type 2 diabetes or insulin resistance and related metabolic disease by significantly reducing fasting blood sugar level and blood insulin level. Also, the composition of the present disclosure exhibits the effect of reducing visceral fat by significantly reducing the expression of nuclear transcription factors (C/EBPα and PPARγ2) playing key roles in adipogenesis or their target gene (aP2), the effect of improving chronically activated inflammation in the visceral fat tissue induced by obesity by significantly reducing the expression of cytokines (TNF-α or IL-6) activating inflammation, and the effect of improving suppressed heat generation in the visceral fat tissue induced by obesity by significantly increasing the expression of UCP (UCP1 or UCP3) genes regulating body heat production. | 02-09-2012 |
| 20150051299 | TREATMENT OF SCHIZOPHRENIA USING BETA-CARYOPHYLLENE AND CB2 RECEPTOR AGONISTS - Disclosed are compositions comprising beta-caryophyllene (BCP) for use in the treatment of schizophrenia, methods of making such compositions and methods of treating schizophrenia using BCP. Disclosed are also compositions comprising CB2 receptor agonists for use in the treatment of schizophrenia, methods of making such compositions and methods of treating schizophrenia using CB2 receptor agonists. | 02-19-2015 |
